BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Business

  PURE Bioscience Announces Partnership with Rockline Industries, Inc. for SDC-Based Products

  April 3, 2008

   · 

  1 min read
• Drug Development

  Protalix Biotherapeutics’s Carfilzomib Receives Orphan Drug Designation for Treatment of Multiple Myeloma

  April 3, 2008

   · 

  3 min read
• Deals

  ActivBiotics’ Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million

  April 3, 2008

   · 

  1 min read
• Business

  Caliper Life Sciences Appoints Peter F. McAree Senior Vice President and Chief Financial Officer

  April 3, 2008

   · 

  1 min read
• FDA

  Masimo Corporation PVI(TM) Cleared for Market in Japan

  April 3, 2008

   · 

  5 min read
• BioForest

  Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review

  April 3, 2008

   · 

  5 min read
• Pharm Country

  Advaxis, Inc. to Present at the LD Micro Growth Conference in Los Angeles, CA

  April 3, 2008

   · 

  1 min read
• Deals

  PharmAthene, Inc. Closes Acquisition of Avecia Biodefense Vaccines Business Unit

  April 3, 2008

   · 

  5 min read
• Biotech Bay

  Advanced Cell Technology Platform Yields Over 140 Cell Types from Human Embryonic Stem Cells

  April 3, 2008

   · 

  1 min read
• Pharm Country

  IDEXX Laboratories, Inc. Announces First Customer Deliveries of Catalyst Dx(TM)

  April 3, 2008

   · 

  3 min read